Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Prestwick3_000351

    Client Email Product

    Prestwick3_000351

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    36
    US DMFs Filed

    US DMFs Filed

    23
    CEP/COS Certifications

    CEP/COS Certifications

    8
    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    6
    Other Suppliers

    Other Suppliers

    17
    API REF. PRICE (USD / KG)
    158

    API Market Place

    18
    INTERMEDIATES
    4
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    116
    Europe

    Europe

    55
    Canada

    Canada

    8
    Australia

    Australia

    2
    South Africa

    South Africa

    5
    Uploaded Dossiers

    Uploaded Dossiers

    8
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    587.00

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS
    203
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    10

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    27
    REF STANDARD

    EDQM

    2

    USP

    1

    JP

    0

    Other Listed Suppliers

    3
    SERVICES
    1
    left grey arrow
    right gray arrow
    • TABLET;ORAL - 100MG;25MG
    • TABLET;ORAL - 50MG;25MG
    • TABLET;ORAL - 15MG
    • TABLET;ORAL - 25MG
    • TABLET;ORAL - EQ 40MG MEDOXOMIL;12.5MG
    • TABLET;ORAL - EQ 40MG MEDOXOMIL;25MG
    • TABLET;ORAL - 25MG
    • TABLET;ORAL - 50MG
    Full View ScreenFull Screen View
    Alkem's Generic Azilsartan Medoxomil, Chlorthalidone Receives Approval in the U.S.
    Alkem's Generic Azilsartan Medoxomil, Chlorthalidone Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217490

    FDA
    28 Nov 2023
    Share Share
    Alembic's Generic Chlorthalidone Receives Approval in the U.S.
    Alembic's Generic Chlorthalidone Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216262

    FDA
    26 Aug 2022
    Share Share
    Mankind Pharma`s Generic Chlorthalidone Receives Approval in the U.S.
    Mankind Pharma`s Generic Chlorthalidone Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215587

    FDA
    04 Aug 2022
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Azilsartan Medoxomil and Chlorthalidomide
    FDA Confirms Paragraph IV Patent Litigation for Azilsartan Medoxomil and Chlorthalidomide

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-azilsartan-medoxomil-and-chlorthalidomide-1655269802.pdf

    FDA
    13 Jun 2022
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Aprepitant, Azilsartan, Bupivacaine, Cladribine, Elrombopag, Fosnetupitant, Fostamatinib, Ivacaftor and Sodium Thiosulfate.
    FDA Confirms Paragraph IV Patent Litigation for Aprepitant, Azilsartan, Bupivacaine, Cladribine, Elrombopag, Fosnetupitant, Fostamatinib, Ivacaftor and Sodium Thiosulfate.

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-aprepitant-azilsartan-bupivacaine-cladribine-elrombopag-fosnetupitant-fostamatinib-ivacaftor-and-sodium-thiosulfate-1655270821.pdf

    FDA
    13 Jun 2022
    Share Share
    Tagi's Generic Chlorthalidone Receives Approval in the U.S.
    Tagi's Generic Chlorthalidone Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212875

    FDA
    24 Feb 2022
    Share Share
    Enforcement Report - Week of February 23, 2022
    Enforcement Report - Week of February 23, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-23-2022-1645600799.pdf

    FDA
    23 Feb 2022
    Share Share
    Inventia's Generic Chlorthalidone Receives Approval in the U.S.
    Inventia's Generic Chlorthalidone Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211320

    FDA
    09 Feb 2022
    Share Share
    Sunny's Generic Chlorthalidone Receives Approval in the U.S.
    Sunny's Generic Chlorthalidone Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209068

    FDA
    25 Jan 2022
    Share Share
    Novitium Pharma’s Generics Atenolol; Chlorthalidone Receives Approvals In US
    Novitium Pharma’s Generics Atenolol; Chlorthalidone Receives Approvals In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215560

    FDA
    28 Oct 2021
    Share Share
    Unichem Labs receives ANDA approval for Atenolol and Chlorthalidone tablets
    Unichem Labs receives ANDA approval for Atenolol and Chlorthalidone tablets

    https://www.livemint.com/companies/news/unichem-labs-receives-anda-approval-for-atenolol-and-chlorthalidone-tablets-11606639120793.html

    J. Jagannath LIVEMINT
    29 Nov 2020
    Share Share
    Alkem Lab`s Generic Chlorthalidone Receives Approval in US
    Alkem Lab`s Generic Chlorthalidone Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213412

    FDA
    15 Feb 2020
    Share Share
    After a brief break, AZ is back at divesting handing off hypertension meds $350M
    After a brief break, AZ is back at divesting handing off hypertension meds $350M

    https://endpts.com/after-a-brief-break-astrazeneca-is-back-at-divesting-handing-off-hypertension-meds-for-350m/

    Amber Tong ENDPTS
    28 Jan 2020
    Share Share
    Unichem Laboratories gets USFDA nod for hypertension management drug
    Unichem Laboratories gets USFDA nod for hypertension management drug

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/unichem-laboratories-gets-usfda-nod-for-hypertension-management-drug/articleshow/70638867.cms

    ECONOMICTIMES
    13 Aug 2019
    Share Share
    Unichem Labs Generic Chlorthalidone Receives Approval in US
    Unichem Labs Generic Chlorthalidone Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211627

    FDA
    09 Aug 2019
    Share Share
    NPPA fixes retail prices of 9 formulations under DPCO, 2013
    NPPA fixes retail prices of 9 formulations under DPCO, 2013

    http://pharmabiz.com/ArticleDetails.aspx?aid=116780&sid=1

    PHARMABIZ
    09 Jul 2019
    Share Share
    AMNEAL PHARMS CO's generic CHLORTHALIDONE Receives Approval in US
    AMNEAL PHARMS CO's generic CHLORTHALIDONE Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207204

    FDA
    01 Jul 2019
    Share Share
    Zydus Pharms USA`s Generic Chlorthalidone Receives Approval in US
    Zydus Pharms USA`s Generic Chlorthalidone Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207813

    FDA
    14 May 2019
    Share Share
    Zydus receives US FDA marketing nod for blood pressure drug chlorthalidone tabs
    Zydus receives US FDA marketing nod for blood pressure drug chlorthalidone tabs

    http://www.pharmabiz.com/NewsDetails.aspx?aid=115722&sid=2

    PHARMABIZ
    13 May 2019
    Share Share
    NPPA fixes retail prices of 22 formulations under DPCO, 2013
    NPPA fixes retail prices of 22 formulations under DPCO, 2013

    http://pharmabiz.com/ArticleDetails.aspx?aid=115527&sid=1

    PHARMABIZ
    06 May 2019
    Share Share
    Zydus Pharms USA`s Generic Atenolol Chlorthalidone Receives Approval in US
    Zydus Pharms USA`s Generic Atenolol Chlorthalidone Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210028

    FDA
    13 Mar 2019
    Share Share
    Invatech Pharma`s Generic Chlorthalidone Receives Approval in US
    Invatech Pharma`s Generic Chlorthalidone Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211063

    FDA
    01 Mar 2019
    Share Share
    Appco Pharma`s Generic Chlorthalidone Receives Approval in US
    Appco Pharma`s Generic Chlorthalidone Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210742

    FDA
    17 Oct 2018
    Share Share
    This Drug Is Safe and Effective. Wait. Compared With What?
    This Drug Is Safe and Effective. Wait. Compared With What?

    https://www.nytimes.com/2018/08/20/upshot/medical-treatments-compared-important-everyday-questions.html

    Aaron E. Carroll NYTIMES
    20 Aug 2018
    Share Share
    Umedica Lab's Generic Chlorthalidone Receives Approval In US
    Umedica Lab's Generic Chlorthalidone Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207222

    FDA
    26 May 2018
    Share Share
    NPPA fixes retail prices of 14 formulations
    NPPA fixes retail prices of 14 formulations

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-fixes-retail-prices-of-14-formulations/articleshow/62338084.cms

    ECONOMIC TIMES
    02 Jan 2018
    Share Share
    FDA Provides Generic Approval Roadmap for 38 Drugs, Including Vertex's Kaldeco
    FDA Provides Generic Approval Roadmap for 38 Drugs, Including Vertex's Kaldeco

    http://www.raps.org/Regulatory-Focus/News/2015/03/09/21677/FDA-Provides-Generic-Approval-Roadmap-for-38-Drugs-Including-Vertexs-Kaldeco/

    Alexander Gaffney RAPS
    11 Mar 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search